Table 1 Descriptive Statistics of Participants
Characteristic | Total Sample (n = 11) | Completed Analysis (n = 8) |
|---|---|---|
Patient Age (mean ± SD) | 12.70 ± 2.06 | 12.75 ± 2.31 |
Gender (female %) | 80 | 80 |
Race (white %) | 90 | 87.5 |
Parental Marital Status (%) | ||
 Single | 20 | 25 |
 Married | 60 | 62.5 |
 Divorced | 10 | 12.5 |
Arthritis Type (%) | ||
 Polyarticular RF-negative | 80 | 75 |
 Extended oligoarticular | 20 | 25 |
Disease Duration (years) | 3.9 ± 3.37 | 3.0 ± 3.05 |
Methotrexate route of administration (%) | ||
 Oral | 55 | 62.5 |
 Subcutaneous | 45 | 37.5 |
Concomitant Biologic (%) | ||
 None | 37 | 25 |
 Etanercept | 9 | 12.5 |
 Adalimumab | 9 | 12.5 |
 Infliximab | 27 | 37.5 |
 Tocilizumab | 18 | 12.5 |
Oral Steroids (%) | 20 | 25 |